Pharmacodynamics, Pharmacokinetics, and Safety of AM211: A Novel and Potent Antagonist of the Prostaglandin D2Receptor Type 2

Pharmacology of AM211, a Potent and Selective Prostaglandin D2 Receptor Type 2 Antagonist That Is Active in Animal Models of Allergic Inflammation

(2011) G. Bain et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Therapeutic efficacy of AM156, a novel prostanoid DP2 receptor antagonist, in murine models of allergic rhinitis and house dust mite-induced pulmonary inflammation

(2010) Karin J. Stebbins et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

DP2receptor antagonists in development

(2010) Peter Norman   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Pharmacological Characterization of MK-7246, a Potent and Selective CRTH2 (Chemoattractant Receptor-Homologous Molecule Expressed on T-Helper Type 2 Cells) Antagonist

(2010) F. G. Gervais et al.   MOLECULAR PHARMACOLOGY

Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis

(2009) George Philip et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Pharmacological Blockade of the DP2 Receptor Inhibits Cigarette Smoke-Induced Inflammation, Mucus Cell Metaplasia, and Epithelial Hyperplasia in the Mouse Lung

(2009) K. J. Stebbins et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

CRTH2 antagonism significantly ameliorates airway hyperreactivity and downregulates inflammation-induced genes in a mouse model of airway inflammation

(2008) Nicholas W. Lukacs et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

CRTH2-dependent, STAT6-independent induction of cedar pollen dermatitis

(2008) M. Oiwa et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Prostaglandin D2 Receptors DP and CRTH2 in the Pathogenesis of Asthma

(2008) Masafumi Arima et al.   CURRENT MOLECULAR MEDICINE

Role of Prostaglandin D2 and Its Receptors in the Pathophysiology of Asthma

(2008) Tsuyoshi Oguma et al.   ALLERGOLOGY INTERNATIONAL